Home Search

organicell - search results

If you're not happy with the results, please do another search

Stem Cell Play Organicell (BPSR) Screams Higher.

Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a...
Organicell

Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...
Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...

Adding Organicell (BPSR) $0.02 to the Watch List.

Organicell (BBSR). New client, studying now. Thinly, thinly traded and expectedly volatile on an intra-day basis. Like what we’ve read so far...

Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.

We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold...

Seven of the World’s Top Performing Stocks, Every Morning

THE TIKI HUT FUND | YESTERDAY'S BIGGEST MOVERS

Heads Up! Big News on Stem Cells & Covid This Weekend.

Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
Biotech Stock Review, Aphex BioCLeanse

Adding Aphex BioCleanse Systems (SNST) to CoronaVirus Watch List.

Former Eastman Kodak Scientist Engineers Develop Liquid Germ Killer Hy-IQ™ Water to Revolutionize how Deadly Bacteria and Virus are Eradicated

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...